XML 66 R51.htm IDEA: XBRL DOCUMENT v3.25.4
INCENTIVE COMPENSATION (Tables)
12 Months Ended
Dec. 28, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Compensation Costs and Income Tax Benefit
Compensation costs and the income tax benefit recognized for our stock-based compensation arrangements are included below:
202520242023
(In thousands)
Equity-based awards compensation cost
Cost of sales$3,233 $2,439 $629 
Selling, general and administrative expense26,121 12,975 6,958 
Total cost29,354 15,414 7,587 
Income tax benefit7,206 3,730 1,836 
Net cost$22,148 $11,684 $5,751 
Liability-based awards compensation cost
Selling, general and administrative expense(a)
$5,453 $(1,953)$2,491 
Income tax benefit (expense)1,339 (473)603 
Net cost(a)
$4,114 $(1,480)$1,888 
(a)During 2024, the liability-based awards in our Europe and Mexico segments for the 2023 performance year were determined to have not met the performance threshold for payout therefore the Company reversed the prior and current year recognized compensation costs related to these awards.
Schedule of RSU Activity
The Company’s RSU activity is included below:
202520242023
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
(In thousands, except weighted average fair values)
Equity-based RSUs
Outstanding at beginning of year1,572 $25.27 911 $22.40 993 $22.00 
Granted1,156 47.72 979 26.80 324 23.67 
Vested(425)26.76 (187)21.76 (378)22.25 
Awards forfeited(153)29.38 (131)21.70 (28)24.99 
Outstanding at end of year2,150 $36.75 1,572 $25.27 911$22.40 
202520242023
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
Number
Weighted Average Milestone Date Fair Value(a)
(In thousands, except weighted average fair values)
Liability-based RSUs
Outstanding at beginning of year24 $45.92 242 $27.66 377 $23.80 
Granted245 52.65 — — 158 24.21 
Vested(15)45.39 — — (196)25.27 
Forfeited(9)45.92 (218)34.32 (97)22.81 
Outstanding at end of year245 $39.82 24 $45.92 242 $27.66 
(a)The milestone date fair value is either the closing price of the Company’s common stock on the grant date for equity-based awards or the closing price of a share of the Company’s common stock on the respective milestone date for cash-based liability-based awards (i.e., grant date, vesting date, forfeiture date or financial reporting date).